Follow the アルフレッサ ホールディングス株式会社 share price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are listed on JP JP, under the supervision of EDINET (Japan FSA). Operating in the Retail sector, アルフレッサ ホールディングス株式会社 has published 9 insider filings. Market capitalisation: €40,190.8bn. The latest transaction was reported on 5 June 2026 (Holding update). Among the most active insiders: Silchester International Investors LLP. The full history is accessible without an account.
Analysts rate アルフレッサ ホールディングス株式会社 Buy (bullish), based on 11 analysts. Average price target: JP¥3,619.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
9 of 9 declarations
Alfresa Holdings Corporation is a Japanese company specializing in the distribution of pharmaceutical and medical products. It primarily operates in the healthcare and medical care market.